Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome-Reference-Cited by-同舟云学术

Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome

Published:2024-07 Issue:7 Volume:6 Page:101075
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Berardi Giammauro^ORCID,Cucchetti Alessandro,Sposito Carlo,Ratti Francesca^ORCID,Nebbia Martina,D’Souza Daniel M.^ORCID,Pascual Franco^ORCID,Dogeas Epameinondas,Tohme Samer^ORCID,Vitale Alessandro^ORCID,D’Amico Francesco Enrico^ORCID,Alessandris Remo^ORCID,Panetta Valentina^ORCID,Simonelli Ilaria^ORCID,Colasanti Marco,Russolillo Nadia,Moro Amika,Fiorentini Guido^ORCID,Serenari Matteo,Rotellar Fernando^ORCID,Zimitti Giuseppe^ORCID,Famularo Simone^ORCID,Ivanics Tommy,Donando Felipe Gaviria,Hoffman Daniel^ORCID,Onkendi Edwin,Essaji Yasmin,Giuliani Tommaso^ORCID,Lopez Ben Santiago^ORCID,Caula Celia^ORCID,Rompianesi Gianluca^ORCID,Chopra Asmita,Abu Hilal Mohammed^ORCID,Sapisochin Gonzalo,Torzilli Guido,Corvera Carlos^ORCID,Alseidi Adnan^ORCID,Helton Scott,Troisi Roberto I.,Simo Kerri^ORCID,Conrad Claudius,Cescon Matteo,Cleary Sean,Kwon David Choon Hyuck,Ferrero Alessandro^ORCID,Ettorre Giuseppe Maria,Cillo Umberto^ORCID,Geller David,Cherqui Daniel,Serrano Pablo E.,Ferrone Cristina,Aldrighetti Luca,Kingham T. Peter,Mazzaferro Vincenzo

Publisher

Elsevier BV

Reference38 articles.

1. Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study;Piscaglia;Hepatology,2016

2. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma;J Hepatol,2018

3. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management;McPherson;J Hepatol,2015

4. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality;Karlsen;Lancet,2022

5. Model to predict major complications following liver resection for HCC in patients with metabolic syndrome;Berardi;Hepatology,2023